Nomura Holdings
DGX icon

Nomura Holdings’s Quest Diagnostics DGX Stock Holding History

Nomura Holdings’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-55,800
Closed -$3.28M – 2816
2014
Q2 		$3.28M Buy
+55,800
New +$3.27M ﹤0.01% 870

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Nomura Holdings's DGX Position: Q1 2026 in Review

Nomura Holdings increased its Quest Diagnostics (DGX) stake by 326% in Q1 2026, buying an estimated $800K and bringing the position to 5,382 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

Nomura Holdings first reported a position in DGX in Q2 2013 and has held it in 32 quarters since. The position peaked at $9.9M in Q4 2013. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Nomura Holdings held 5,382 shares of Quest Diagnostics worth $1.05M as of Q1 2026.
  • Nomura Holdings bought 4,120 Quest Diagnostics shares in Q1 2026, an estimated $800K.
  • Quest Diagnostics made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1142 holding.
  • Nomura Holdings first reported a position in Quest Diagnostics in Q2 2013 and has held it in 32 quarters since.
  • Nomura Holdings's Quest Diagnostics position peaked at $9.9M in Q4 2013.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.